BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18596484)

  • 1. A once-a-year intravenous treatment of osteoporosis in postmenopausal women: implications for the clinical nurse specialist.
    O'Malley P
    Clin Nurse Spec; 2008; 22(4):169-71. PubMed ID: 18596484
    [No Abstract]   [Full Text] [Related]  

  • 2. Annual zoledronic acid for osteoporosis.
    BMJ Group
    Drug Ther Bull; 2008 Dec; 46(12):93-6. PubMed ID: 19056701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic acid--once-yearly. Corticosteroid-induced osteoporosis: no benefit.
    Prescrire Int; 2010 Apr; 19(106):63. PubMed ID: 20568485
    [No Abstract]   [Full Text] [Related]  

  • 4. [Osteoporosis and bisphosphonates].
    Zuber MA
    Z Rheumatol; 2007 Dec; 66(8):713-5. PubMed ID: 17955251
    [No Abstract]   [Full Text] [Related]  

  • 5. A once-yearly IV bisphosphonate for osteoporosis.
    Med Lett Drugs Ther; 2007 Nov; 49(1273):89-90. PubMed ID: 17975523
    [No Abstract]   [Full Text] [Related]  

  • 6. Zoledronic acid: new indication. No therapeutic advantage in postmenopausal osteoporosis.
    Prescrire Int; 2008 Aug; 17(96):143. PubMed ID: 19480098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronate once-yearly increases bone mineral density--implications for osteoporosis.
    Doggrell SA
    Expert Opin Pharmacother; 2002 Jul; 3(7):1007-9. PubMed ID: 12083999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CALGB 78909: Phase III trial of intravenous zoledronic acid in the prevention of bone loss in localized breast cancer patients with chemotherapy-induced ovarian failure.
    Clin Adv Hematol Oncol; 2005 Feb; 3(2):105-6. PubMed ID: 16166977
    [No Abstract]   [Full Text] [Related]  

  • 9. Biennial [corrected] IV zoledronic acid (Reclast) for prevention of osteoporosis.
    Med Lett Drugs Ther; 2009 Jun; 51(1315):49. PubMed ID: 19556940
    [No Abstract]   [Full Text] [Related]  

  • 10. Consultation corner. Bone loss drug gives users a break.
    Bellantoni M
    Johns Hopkins Med Lett Health After 50; 2007 Dec; 19(10):6. PubMed ID: 18225340
    [No Abstract]   [Full Text] [Related]  

  • 11. A once-yearly IV bisphosphonate for osteoporosis.
    Obstet Gynecol; 2008 May; 111(5):1208-9. PubMed ID: 18448761
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis.
    Hagino H; Nishizawa Y; Sone T; Morii H; Taketani Y; Nakamura T; Itabashi A; Mizunuma H; Ohashi Y; Shiraki M; Minamide T; Matsumoto T
    Bone; 2009 Jun; 44(6):1078-84. PubMed ID: 19264155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates: a once-yearly treatment option with Reclast.
    Van Gilder D
    S D Med; 2008 Nov; 61(11):416-7. PubMed ID: 19066136
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclic administration of pamidronate to treat osteoporosis in children with cerebral palsy or a neuromuscular disorder: a clinical study.
    Allington N; Vivegnis D; Gerard P
    Acta Orthop Belg; 2005 Feb; 71(1):91-7. PubMed ID: 15792214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent low-dose bisphosphonate therapy.
    Clézardin P
    Bone; 2007 Nov; 41(5):901-2. PubMed ID: 17869599
    [No Abstract]   [Full Text] [Related]  

  • 16. [Once-yearly administration of zoledronic acid to treat post-menopausal osteoporosis].
    Seitz S; Schieker M; Mutschler W
    Unfallchirurg; 2009 Mar; 112(3):346-8. PubMed ID: 19240992
    [No Abstract]   [Full Text] [Related]  

  • 17. Corticosteroids: no drug prevention of fractures needed.
    Prescrire Int; 2009 Aug; 18(102):175. PubMed ID: 19746563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zoledronate.
    Delmas PD
    Br J Clin Pract Suppl; 1996 Sep; 87():15 discussion 22. PubMed ID: 8995012
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized clinical trials of raloxifene: reducing the risk of osteoporosis and breast cancer in postmenopausal women.
    Olevsky OM; Martino S
    Menopause; 2008; 15(4 Suppl):790-6. PubMed ID: 18596600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance.
    Boonen S; Vanderschueren D; Venken K; Milisen K; Delforge M; Haentjens P
    J Intern Med; 2008 Oct; 264(4):315-32. PubMed ID: 18823505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.